Adicet Bio (ACET) Other financing activities (2018 - 2025)

Adicet Bio has reported Other financing activities for 8 years, with the latest figure at $74.9 million in Q4 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $74.9 million in Q4 2025; TTM through Dec 2025 was $75.2 million, a 17.98% decrease from a year earlier, with the FY2025 full-year figure at $75.2 million, down 17.98% from the prior year.
• Other financing activities was $74.9 million for Q4 2025 at Adicet Bio, up from $267000.0 in the prior quarter.
• The five-year high for Other financing activities was $91.7 million in Q1 2024, with the low at $3000.0 in Q1 2023.
• Average Other financing activities over 5 years is $12.4 million, with a median of $273000.0 recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Other financing activities slumped 96.81% in 2023, then surged 3054966.67% in 2024.
• Over 5 years, Other financing activities stood at $3.1 million in 2021, then tumbled by 72.37% to $847000.0 in 2022, then tumbled by 81.46% to $157000.0 in 2023, then surged by 58277.07% to $91.7 million in 2024, then retreated by 18.27% to $74.9 million in 2025.
• The last three Other financing activities figures came in at $74.9 million (Q4 2025), $267000.0 (Q2 2025), and $91.7 million (Q1 2024), per Business Quant data.